Go Deep
AbbVie Inc.
AbbVie Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | -53,312 | 74.5 | -78.70 | -0.74 | 25,358.79 |
| Oct 2026 | -56,963 | 74.2 | -78.24 | -0.74 | 25,277.24 |
| Oct 2026 | -56,963 | 74.2 | -78.24 | -0.74 | 25,277.24 |
| Oct 2026 | -57,456 | 75.1 | -79.12 | -0.74 | 25,560.00 |
| Oct 2026 | -57,612 | 75.3 | -79.40 | -0.74 | 25,713.73 |
| Oct 2026 | -57,611 | 75.1 | -79.40 | -0.74 | 25,713.73 |
| Oct 2026 | -58,293 | 76.4 | -80.79 | -0.74 | 26,195.96 |
| Oct 2026 | -58,471 | 77.0 | -81.10 | -0.74 | 26,298.29 |
| Oct 2026 | -59,100 | 78.1 | -82.31 | -0.74 | 26,750.24 |
| Oct 2026 | -29,956 | 79.4 | -83.69 | -20.64 | 26,914.58 |
| Oct 2026 | -80,401 | 77.5 | -81.69 | -20.64 | 26,128.32 |
| Oct 2026 | -81,885 | 80.1 | -84.41 | -20.64 | 26,915.72 |
| Oct 2026 | -81,768 | 77.4 | -84.38 | -20.64 | 26,911.96 |
| Oct 2026 | -82,106 | 80.6 | -84.98 | -20.64 | 27,033.54 |
| Oct 2026 | -81,650 | 79.9 | -84.17 | -20.64 | 26,802.70 |
| Oct 2026 | -82,715 | 81.7 | -86.07 | -20.64 | 27,409.52 |
| Oct 2026 | -82,003 | 80.5 | -84.80 | -20.64 | 26,937.00 |
| Oct 2026 | -82,068 | 80.6 | -84.91 | -20.64 | 26,919.32 |
| Oct 2026 | -82,142 | 80.7 | -85.05 | -20.64 | 27,073.58 |
AbbVie Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 16,990,000,000.0 | 15,002,000,000.0 | 16,618,000,000.0 | 15,776,000,000.0 |
| Net Profit | 3,613,000,000.0 | 695,000,000.0 | 1,816,000,000.0 | 186,000,000.0 |
| EPS | 2.0 | 0.4 | 1.0 | 0.1 |
AbbVie Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 61,160,000,000.0 | 56,334,000,000.0 | 54,318,000,000.0 | 58,054,000,000.0 |
| Net Profit | 4,226,000,000.0 | 4,278,000,000.0 | 4,863,000,000.0 | 11,836,000,000.0 |
| EPS | 2.4 | 2.4 | 2.8 | 6.7 |
AbbVie Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 133,960,000,000.0 | 135,161,000,000.0 | 134,711,000,000.0 | 138,805,000,000.0 | — |
| Total Liabilities | 137,188,000,000.0 | 131,797,000,000.0 | 124,314,000,000.0 | 121,518,000,000.0 | — |
| Total Equity | -3,270,000,000.0 | 3,325,000,000.0 | 10,360,000,000.0 | 17,254,000,000.0 | — |
Owes vs Owns
AbbVie Inc. owed $1.04 for every $1 it owned in Jun 2026, up from $0.88 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.04× | 1.02× | 0.98× | 0.92× | 0.88× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
AbbVie Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 3.9%Receivables 9.4%Inventory 3.7%Fixed assets (tangible) 4.2%Intangible assets 65.9%Other assets 12.7%
How it's funded — Dec 2025
Short-term debt 6.2%Long-term debt 43.0%Payables 2.6%Other liabilities 48.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 5,257.0 | 5,555.0 | 12,816.0 | 9,229.0 |
| Receivables | 12,589.0 | 10,919.0 | 11,155.0 | 11,254.0 |
| Inventory | 4,951.0 | 4,181.0 | 4,099.0 | 3,579.0 |
| Fixed assets (tangible) | 5,628.0 | 5,134.0 | 4,989.0 | 4,935.0 |
| Intangible assets | 88,281.0 | 95,024.0 | 87,903.0 | 99,595.0 |
| Long-term investments | 268.0 | 279.0 | 304.0 | 241.0 |
| Other assets | 16,986.0 | 14,069.0 | 13,445.0 | 9,972.0 |
| Liabilities & equity | ||||
| Short-term debt | 8,555.0 | 6,804.0 | 7,191.0 | 4,136.0 |
| Long-term debt | 58,941.0 | 60,340.0 | 52,194.0 | 59,135.0 |
| Payables | 3,592.0 | 2,945.0 | 3,688.0 | 2,934.0 |
| Other liabilities | 66,100.0 | 61,708.0 | 61,241.0 | 55,313.0 |
| Shareholders' equity | -3,228.0 | 3,364.0 | 10,397.0 | 17,287.0 |
| Net tangible assets | -91,551.0 | -91,699.0 | -77,543.0 | -82,341.0 |
AbbVie Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 19,030,000,000.0 | 18,806,000,000.0 | 22,839,000,000.0 | 24,943,000,000.0 | — |
| Investing Activities | -6,643,000,000.0 | -20,820,000,000.0 | -2,009,000,000.0 | -623,000,000.0 | — |
| Financing Activities | -12,724,000,000.0 | -5,211,000,000.0 | -17,222,000,000.0 | -24,803,000,000.0 | — |